Action 600252 GUANGXI WUZHOU ZHONGHENG GROUP CO.,LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Guangxi Wuzhou Zhongheng Group Co.,Ltd

Actions

600252

CNE0000015F9

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 16/05/2024 		Varia. 5j. Varia. 1 janv.
2,46 CNY -0,81% Graphique intraday de Guangxi Wuzhou Zhongheng Group Co.,Ltd -1,60% -1,99%
29/04 Guangxi Wuzhou Zhongheng Group Co, Ltd présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI
17/04 Guangxi Wuzhou Zhongheng Group Co. Ltd (SHSE:600252) commence un rachat d'actions pour une valeur de 200 millions CNY, dans le cadre de l'autorisation approuvée le 28 mars 2024. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.
Guangxi Honggui Capital Operation Group Co.,Ltd. agreed to acquire 18% stake in Guangxi United Asset Management Co., Ltd from Guangxi Wuzhou Zhongheng Group Co.,Ltd for approximately CNY 190 million.
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug
Wuzhou Zhongheng’s Drug For Preventing Chemotherapy-Related Nausea Passes Consistency Test
Sealand Securities Co., Ltd. announced that it has received CNY 3.192189985 billion in funding from a group of investors
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to S&P Global BMI Index
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to FTSE All-World Index
Wuzhou Zhongheng Gets Nod to Trial Ovarian Cancer Drug
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Guangxi Wuzhou Zhongheng Receives 42 Million Yuan in Government Subsidy
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Restrictions on Guangxi Wuzhou Zhongheng Drugs in 2022 Chinese Drug Catalogue Amended
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from S&P Global BMI Index
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from FTSE All-World Index
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 600252
  4. Actualités Guangxi Wuzhou Zhongheng Group Co.,Ltd
  5. Autres langues